BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4149379)

  • 1. Mechanisms of inhibition of drug metabolic reactions.
    Gillette J; Sasame H; Stripp B
    Drug Metab Dispos; 1973; 1(1):164-75. PubMed ID: 4149379
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the molecular function of cytochrome P-450 during drug metabolism.
    Estabrook RW; Matsubara T; Mason JI; Werringloer J; Baron J
    Drug Metab Dispos; 1973; 1(1):98-110. PubMed ID: 4149428
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the effects of methylmercury on ethylmorphine N-demethylase and aniline hydroxylase activities and on the conversion of cytochrome P-450 to cytochrome P-420.
    Alvares AP; Cohn J; Kappas A
    Drug Metab Dispos; 1974; 2(3):259-66. PubMed ID: 4153087
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between NADH and NADPH oxidation during drug metabolism.
    Sasame HA; Mitchell JR; Thorgeirsson S; Gillette JR
    Drug Metab Dispos; 1973; 1(1):150-5. PubMed ID: 4129866
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of cytochrome P-450 in N-hydroxylation of 2-acetylaminofluorene.
    Thorgeirsson SS; Jollow DJ; Sasame HA; Green I; Mitchell JR
    Mol Pharmacol; 1973 May; 9(3):398-404. PubMed ID: 4122821
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of synergists on drug metabolism.
    Hodgson E; Philpot RM; Baker RC; Mailman RB
    Drug Metab Dispos; 1973; 1(1):391-401. PubMed ID: 4149410
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate: effect of drug substrates.
    Gigon PL; Gram TE; Gillette JR
    Mol Pharmacol; 1969 Mar; 5(2):109-22. PubMed ID: 4389181
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of cytochrome P-450 in mixed function oxidation and metabolism of anesthetics].
    Shigematsu A; Takahashi S; Furukawa T
    Masui; 1974 Feb; 23(2):89-98. PubMed ID: 4603810
    [No Abstract]   [Full Text] [Related]  

  • 9. Perinatal development of tertiary amine N-oxidation and NADPH cytochrome C reduction in rat liver microsomes.
    Uehleke H; Reiner O; Hellmer KH
    Res Commun Chem Pathol Pharmacol; 1971 Nov; 2(6):793-805. PubMed ID: 4405002
    [No Abstract]   [Full Text] [Related]  

  • 10. Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. VIII. Different catalytic activities of rabbit and rat cytochromes P-448.
    Kawalek JC; Lu AY
    Mol Pharmacol; 1975 Mar; 11(2):201-10. PubMed ID: 235734
    [No Abstract]   [Full Text] [Related]  

  • 11. Sex-dependent differences in drug metabolism in the rat. 3. Temporal changes in type I binding and NADPH-cytochrome, P-450 reductase during sexual maturation.
    Cohen GM; Mannering GJ
    Drug Metab Dispos; 1974; 2(3):285-92. PubMed ID: 4153061
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the relationship between the effects of various substances on absorption spectrum of cytochrome P-450 and the reduction of p-nitrobenzoate by mouse liver microsomes.
    Sasame HA; Gillette JR
    Mol Pharmacol; 1969 Mar; 5(2):123-30. PubMed ID: 4389182
    [No Abstract]   [Full Text] [Related]  

  • 13. The characterization of an inhibitory complex formed with cytochrome P-450 and a metabolite of 1,1-disubstituted hydrazines.
    Hines RN; Prough RA
    J Pharmacol Exp Ther; 1980 Jul; 214(1):80-6. PubMed ID: 7391974
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver microsomal metabolism of N-methylcarbazole: a probe for induction, inhibition, and species differences.
    Koop DR; Hollenberg PF
    Mol Pharmacol; 1980 Jan; 17(1):118-27. PubMed ID: 7383014
    [No Abstract]   [Full Text] [Related]  

  • 15. On the mechanism of hydroxylation reactions catalyzed by cytochrome P-450.
    Coon MJ; Strobel HW; Boyer RF
    Drug Metab Dispos; 1973; 1(1):92-7. PubMed ID: 4149427
    [No Abstract]   [Full Text] [Related]  

  • 16. Interindividual differences in rates of drug oxidation in man.
    Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
    Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of ionizing radiation on the activity of drug-metabolizing enzymes of the endoplasmic reticulum (review of the literature)].
    Khalilov EM; Bol'shev VN
    Farmakol Toksikol; 1976; 39(4):500-6. PubMed ID: 17548
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inactivation of microsomal proteins by lysosomes (author's transl)].
    Betz H; Gratzl M; Remmer H
    Hoppe Seylers Z Physiol Chem; 1973 May; 354(5):567-75. PubMed ID: 4154275
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and degradation of microsomal hemoproteins.
    Schmid R
    Drug Metab Dispos; 1973; 1(1):256-8. PubMed ID: 4149391
    [No Abstract]   [Full Text] [Related]  

  • 20. Some selected studies on hepatic microsomal drug-metabolizing enzymes--environment interactions.
    Fouts JR
    Drug Metab Dispos; 1973; 1(1):380-5. PubMed ID: 4149408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.